Cancer Research
Study findings from Harvard University, U.S., advance cancer knowledge
Published in Gene Therapy Weekly, January 4th, 2007
Study 1: According to recently published research from the United States, human neural stem cells (NSCs) target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
"Medulloblastoma, a malignant pediatric brain tumor, is incurable in about one third of patients despite multimodal treatments. In addition, current therapies can lead to long-term disabilities.
"Based on studies of the extensive tropism of neural stem cells (NSC) toward malignant gliomas and the secretion of growth factors common to glioma...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-01-04)
More Articles from Gene Therapy Weekly
- Gene Research
Pioneers in field of functional genomics work toward gene therapy for vision defects - Gene Research
Targeting a single gene could inhibit bone decay and stimulate bone growth - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at University of California - Cancer Gene Therapy
Data on cancer gene therapy published by researchers at Cornell University - Cancer Gene Therapy
Investigators at West Virginia University, Mary Babb Randolph Cancer Center release new data on cancer gene therapy - Cancer Gene Therapy
New cancer gene therapy research from Nagoya University, Department of Biochemistry discussed - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
